secwatch.observer — SEC 8-K summary
======================================

Issuer:     Apexigen, Inc. (—)
CIK:        0001814140
Form:       8-K
Filed at:   2023-04-12T23:59:59+00:00
Accession:  0000950170-23-012571
Event type: regulatory
Sentiment:  negative
Materiality: 0.65
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Apexigen receives Nasdaq notice for bid price non-compliance; 180-day cure period
--------------------------------------------------------------------------------

- Nasdaq notified Apexigen on April 11, 2023 that its common stock failed to meet minimum $1.00 bid price for 30 consecutive business days.
- Company has 180 calendar days to regain compliance by closing at $1.00 for at least 10 consecutive business days.
- If not cured, a second 180-day period may be available if other listing standards are met and company notifies Nasdaq of intent to reverse split.
- Failure to regain compliance could lead to delisting of APGN and APGNW from Nasdaq Capital Market.
- Apexigen intends to monitor bid price and explore actions but gives no assurance of regaining compliance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1814140/000095017023012571/0000950170-23-012571-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1814140/000095017023012571/apgn-20230411.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-012571

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer